NXTCL.ST
Price:
$0.726
Market Cap:
$80.87M
NextCell Pharma AB, a biopharmaceutical company, engages in the research and development of novel stem cell therapies in Sweden. The company develops ProTrans, a drug candidate comprising stem cells primarily for treating autoimmune and inflammatory diseases. It also provides Cellaviva, a stem cell bank for the family-saving of stem cells from umbilical cord blood and umbilical cord tissue. NextCell Pharma AB was incorporated in 2014 and is based in Huddinge, Sweden.
Industry
Biotechnology
IPO Date
2017-07-13
Stock Exchange
STO
Ticker
NXTCL.ST
According to NextCell Pharma AB’s latest financial reports and current stock price. The company's current Current Ratio is 10.02. This represents a change of 33.60% compared to the average of 7.50 of the last 4 quarters.
The mean historical Current Ratio of NextCell Pharma AB over the last ten years is 11.02. The current 10.02 Current Ratio has changed 9.00% with respect to the historical average. Over the past ten years (40 quarters), NXTCL.ST's Current Ratio was at its highest in in the February 2021 quarter at 45.34. The Current Ratio was at its lowest in in the November 2015 quarter at 0.
Average
11.02
Median
8.92
Minimum
1.86
Maximum
37.02
Discovering the peaks and valleys of NextCell Pharma AB Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 342.10%
Maximum Annual Current Ratio = 37.02
Minimum Annual Increase = -80.64%
Minimum Annual Current Ratio = 1.86
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 10.02 | 63.21% |
| 2024 | 6.14 | -7.99% |
| 2023 | 6.67 | -56.66% |
| 2022 | 15.40 | -58.40% |
| 2021 | 37.02 | 209.27% |
| 2020 | 11.97 | 45.39% |
| 2019 | 8.23 | 342.10% |
| 2018 | 1.86 | -80.64% |
| 2017 | 9.62 | 198.40% |
| 2016 | 3.22 | -34.42% |
The current Current Ratio of NextCell Pharma AB (NXTCL.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.61
5-year avg
15.05
10-year avg
11.02
NextCell Pharma AB’s Current Ratio is greater than Active Biotech AB (publ) (1.17), greater than Pila Pharma AB (publ) (0.95), greater than Biovica International AB (publ) (0.86), greater than Nanologica AB (publ) (2.50), greater than Biosergen AB (7.09), greater than Sprint Bioscience AB (publ) (1.13), greater than Scandinavian ChemoTech AB (publ) (1.17), greater than Immunovia AB (publ) (1.91), greater than Iconovo AB (publ) (2.35), greater than Spago Nanomedical AB (publ) (3.95),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.17 | $74.06M | |
| 0.95 | $95.95M | |
| 0.86 | $104.93M | |
| 2.50 | $67.51M | |
| 7.09 | $117.41M | |
| 1.13 | $154.05M | |
| 1.17 | $86.97M | |
| 1.91 | $85.97M | |
| 2.35 | $65.53M | |
| 3.95 | $36.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NextCell Pharma AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NextCell Pharma AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is NextCell Pharma AB's Current Ratio?
How is the Current Ratio calculated for NextCell Pharma AB (NXTCL.ST)?
What is the highest Current Ratio for NextCell Pharma AB (NXTCL.ST)?
What is the 3-year average Current Ratio for NextCell Pharma AB (NXTCL.ST)?
What is the 5-year average Current Ratio for NextCell Pharma AB (NXTCL.ST)?
How does the current Current Ratio for NextCell Pharma AB (NXTCL.ST) compare to its historical average?